fig7
Figure 7. The effect of L. johnsonii CCFM1376 on the FXR signaling pathway in hypercholesterolemic mice. (A) FXR in the ileum; (B) FGF15; (C) FXR in the liver; (D) SHP; (E) CYP7A1. Different letters in each group indicated significant differences (P < 0.05). FXR: Farnesoid X receptor; FGF15: fibroblast growth factor 15; SHP: small heterodimer partner.
